Amphetamine reduces vesicular dopamine content in dexamethasone- differentiated PC12 cells only following l-DOPA exposure

Journal of Neurochemistry

Volumn 111, Issue 2, 2009, Pages 624-633

  Hondebrink, Laura ^a,b   Meulenbelt, Jan ^a,b,c   Timmerman, Johan G ^a   Van Den Berg, Martin ^a   Westerink, Remco H S ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Amperometry; Ca2+ homeostasis; Drugs of abuse; Exocytosis; Large dense core vesicle; Vesicular catecholamine release

Indexed keywords

AMPHETAMINE; DEXAMETHASONE; DOPAMINE; FURA 2; LEVODOPA;

AMPEROMETRY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM CELL LEVEL; CELL STRAIN; CELL VIABILITY; CHROMAFFIN CELL; CONTROLLED STUDY; EXOCYTOSIS; FEMALE; LONG TERM EXPOSURE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSPORT VESICLE;

AMPHETAMINE; ANIMALS; CALCIUM; CELL DIFFERENTIATION; CELL SURVIVAL; CHROMAFFIN CELLS; DEXAMETHASONE; DOPAMINE; DOPAMINE AGENTS; DRUG INTERACTIONS; FEMALE; GLUCOCORTICOIDS; LEVODOPA; MALE; MICE; MICE, INBRED C57BL; NEURONS; PC12 CELLS; RATS; SYNAPTIC VESICLES;

EID: 70349303550     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06357.x     Document Type: Article

References (42)

1. Campos-Caro A., Smillie F. I., Dominguez del Toro E. et al. (1997) Neuronal nicotinic acetylcholine receptors on bovine chromaffin cells: cloning, expression, and genomic organization of receptor subunits. J. Neurochem. 68, 488 497.
2. Colliver T. L., Pyott S. J., Achalabun M. Ewing A. G. (2000a) VMAT-Mediated changes in quantal size and vesicular volume. J. Neurosci. 20, 5276 5282.
3. Colliver T. L., Hess E. J., Pothos E. N., Sulzer D. Ewing A. G. (2000b) Quantitative and statistical analysis of the shape of amperometric spikes recorded from two populations of cells. J. Neurochem. 74, 1086 1097.
4. De Camilli P. Jahn R. (1990) Pathways to regulated exocytosis in neurons. Annu. Rev. Physiol. 52, 625 645.
5. 2+ und pH, Ionenmessungen in Zellen und Geweben (Wigger F. Mechler M., eds pp. 77 97. Spektrum Akademischer Verlag, Heidelberg.
6. Denizot F. Lang R. (1986) Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 89, 271 277.
7. Dingemans M. M., Ramakers G. M., Gardoni F., van Kleef R. G., Bergman A., Di Luca M., van den Berg M., Westerink R. H. Vijverberg H. P. (2007) Neonatal exposure to brominated flame retardant BDE-47 reduces long-term potentiation and postsynaptic protein levels in mouse hippocampus. Environ. Health Perspect. 115, 865 870.
8. El-Hajj R. A., McKay S. B. McKay D. B. (2007) Pharmacological and immunological identification of native alpha7 nicotinic receptors: evidence for homomeric and heteromeric alpha7 receptors. Life Sci. 81, 1317 1322.
9. Ellenhorn M. J. Barceloux D. G. (1988) Medical Toxicology. Diagnosis and Treatment of Human Poisoning. Elseviers Science Publishing Co, New York.
10. Erickson J. D., Schafer M. K., Bonner T. I., Eiden L. E. Weihe E. (1996) Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. Proc. Natl. Acad. Sci. USA 93, 5166 5171.
11. Floor E. Meng L. (1996) Amphetamine releases dopamine from synaptic vesicles by dual mechanisms. Neurosci. Lett. 215, 53 56.
12. Fornai F., Lenzi P., Lazzeri G., Ferrucci M., Fulceri F., Giorgi F. S., Falleni A., Ruggieri S. Paparelli A. (2007) Fine ultrastructure and biochemistry of PC12 cells: a comparative approach to understand neurotoxicity. Brain Res. 1129, 174 190.
13. Gonzalez-Nicolini V. McGinty J. F. (2002) Gene expression profile from the striatum of amphetamine-treated rats: a cDNA array and in situ hybridization histochemical study. Brain Res Gene Expr Patterns 1, 193 198.
14. Greene L. A. Tischler A. S. (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA 73, 2424 2428.
15. Holmgren A., Holmgren P., Kugelberg F. C., Jones A. W. Ahlner J. (2008) High re-arrest rates among drug-impaired drivers despite zero-tolerance legislation. Accid. Anal. Prev. 40, 534 540.
16. Jones S. R., Gainetdinov R. R., Wightman R. M. Caron M. G. (1998) Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J. Neurosci. 18, 1979 1986.
17. Kahlig K. M. Galli A. (2003) Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine. Eur. J. Pharmacol. 479, 153 158. (Pubitemid 37377884)
18. Kantor L., Zhang M., Guptaroy B., Park Y. H. Gnegy M. E. (2004) Repeated amphetamine couples norepinephrine transporter and calcium channel activities in PC12 cells. J. Pharmacol. Exp. Ther. 311, 1044 1051.
19. Leszczyszyn D. J., Jankowski J. A., Viveros O. H., Diliberto E. J. Jr., Near J. A. Wightman R. M. (1991) Secretion of catecholamines from individual adrenal medullary chromaffin cells. J. Neurochem. 56, 1855 1863.
20. 2+ entry and catecholamine release via nicotinic receptor activation in bovine adrenal chromaffin cells. Eur. J. Pharmacol. 460, 9 17.
21. Lopez M. G., Montiel C., Herrero C. J. et al. (1998) Unmasking the functions of the chromaffin cell alpha7 nicotinic receptor by using short pulses of acetylcholine and selective blockers. Proc. Natl. Acad. Sci. USA 95, 14184 14189.
22. Mundorf M. L., Hochstetler S. E. Wightman R. M. (1999) Amine weak bases disrupt vesicular storage and promote exocytosis in chromaffin cells. J. Neurochem. 73, 2397 2405.
23. Partilla J. S., Dempsey A. G., Nagpal A. S., Blough B. E., Baumann M. H. Rothman R. B. (2006) Interaction of amphetamines and related compounds at the vesicular monoamine transporter. J. Pharmacol. Exp. Ther. 319, 237 246.
24. Peter D., Jimenez J., Liu Y., Kim J. Edwards R. H. (1994) The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors. J. Biol. Chem. 269, 7231 7237.
25. Peters F. T., Samyn N., Wahl M., Kraemer T., De Boeck G. Maurer H. H. (2003) Concentrations and ratios of amphetamine, methamphetamine, MDA, MDMA, and MDEA enantiomers determined in plasma samples from clinical toxicology and driving under the influence of drugs cases by GC-NICI-MS. J. Anal. Toxicol. 27, 552 559.
26. Pothos E., Desmond M. Sulzer D. (1996) l-3,4-dihydroxyphenylalanine increases the quantal size of exocytotic dopamine release in vitro. J. Neurochem. 66, 629 636.
27. Schonn J., Desnos C., Henry J. Darchen F. (2003) Transmitter uptake and release in PC12 cells overexpressing plasma membrane monoamine transporters. J. Neurochem. 84, 669 677.
28. Seguela P., Wadiche J., Dineley-Miller K., Dani J. A. Patrick J. W. (1993) Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium. J. Neurosci. 13, 596 604.
29. Sombers L. A., Maxson M. M. Ewing A. G. (2005) Loaded dopamine is preferentially stored in the halo portion of PC12 cell dense core vesicles. J. Neurochem. 93, 1122 1131.
30. Sulzer D. Rayport S. (1990) Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action. Neuron 5, 797 808.
31. Sulzer D., Maidment N. T. Rayport S. (1993) Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. J. Neurochem. 60, 527 535.
32. Sulzer D., Chen T. K., Lau Y. Y., Kristensen H., Rayport S. Ewing A. (1995) Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J. Neurosci. 15, 4102 4108.
33. Sulzer D., Sonders M. S., Poulsen N. W. Galli A. (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog. Neurobiol. 75, 406 433.
34. Verschraagen M., Maes A., Ruiter B., Bosman I. J., Smink B. E. Lusthof K. J. (2007) Post-mortem cases involving amphetamine-based drugs in The Netherlands. Comparison with driving under the influence cases. Forensic Sci. Int. 170, 163 170.
35. Vizi E. S. (1998) Different temperature dependence of carrier-mediated (cytoplasmic) and stimulus-evoked (exocytotic) release of transmitter: a simple method to separate the two types of release. Neurochem. Int. 33, 359 366.
36. Vizi E. S., Palkovits M., Lendvai B., Baranyi M., Kovacs K. J. Zelles T. (2004) Distinct temperature-dependent dopamine-releasing effect of drugs of abuse in the olfactory bulb. Neurochem. Int. 45, 63 71.
37. Westerink R. H. (2006) Targeting exocytosis: ins and outs of the modulation of quantal dopamine release. CNS Neurol Disord Drug Targets 5, 57 77.
38. (2+). J. Neurochem. 80, 861 873.
39. Westerink R. H., de Groot A. Vijverberg H. P. (2000) Heterogeneity of catecholamine-containing vesicles in PC12 cells. Biochem. Biophys. Res. Commun. 270, 625 630.
40. 28K in vesicular catecholamine release from mouse chromaffin cells. J. Neurochem. 99, 628 640.
41. Winkler H. Fischer-Colbrie R. (1992) The chromogranins A and B: the first 25 years and future perspectives. Neuroscience 49, 497 528.
42. Yao J., Erickson J. D. Hersh L. B. (2004) Protein kinase A affects trafficking of the vesicular monoamine transporters in PC12 cells. Traffic 5, 1006 1016.